首页|小剂量阿司匹林预防剖宫产术后下肢静脉血栓的临床效果和安全性分析

小剂量阿司匹林预防剖宫产术后下肢静脉血栓的临床效果和安全性分析

扫码查看
目的 探讨小剂量阿司匹林预防剖宫产术后下肢深静脉血栓的临床效果和安全性.方法 选择2016年1月~2017年3月在淳安县第一人民医院妇产科剖宫产的产妇374例作为研究对象,采用随机数字表法按1:1比例将产妇分为对照组和观察组,每组各187例,对照组剖宫产术后给予常规综合性预防措施,观察组在对照组的基础上给予小剂量阿司匹林治疗.观察2组产后1个月内下肢深静脉血栓发生率,比较术后12 h与术后7 d时血清D-二聚体(D-D)、纤维蛋白原(FIB)、活化部分凝血酶时间(APTT)、凝血酶原时间(PT)、血小板数量(PLT)和血流变指标,统计2组出血性并发症发生率.结果 观察组下肢深静脉血栓发生率显著低于对照组,差异具有统计学意义(P<0.05);2组术后5 d时D-D和FIB与术后12 h相比均显著降低,差异具有统计学意义(P<0.05),且观察组与同期对照组相比均显著降低,差异具有统计学意义(P<0.05);2组术后PT、APTT、PLT与术前相比较差异无统计学意义,且观察组与同期对照组相比较差异均无统计学意义;2组术后7 d时全血高切黏度、全血中切黏度、全血低切黏度、血浆黏度与术后12 h相比较均显著降低(P<0.05),且观察组与同期对照组相比较均显著降低(P<0.05);术后7 d时红细胞变形指数与术后12 h相比较均显著升高(P<0.05),且观察组与同期对照组相比较显著升高(P<0.05);2组术后出血性并发症发生率无统计学意义.结论 小剂量阿司匹林有助于改善剖宫产术后产妇的高凝状态,降低血液黏滞程度,减少下肢静脉血栓的发生率,不会增加出血的发生概率,临床应用安全性良好,具有临床推广价值.
Clinical effect and safety of low dose aspirin in preventing lower extremity venous thrombosis after cesarean section
Objective To investigate the clinical efficacy and safety of low-dose aspirin in prevention of lower extremity deep venous thrombosis after cesarean section. Methods from January 2016 to March 2017 in our hospital obstetrics and Gynecology cesarean section in 374 cases as the research object, using the method of random number table according to the proportion of 1:1 were divided into control group and observation group, each group of the 187 cases, the control group after cesarean section treated with routine comprehensive preventive measures, the observation group in the control group received the low-dose aspirin treatment. Observation group 2 postpartum in January the incidence of deep venous thrombosis, postoperative 12 h, postoperative serum 7 d two D- dimer (D-D), fibrinogen (FIB), activated partial thromboplastin time (APTT), prothrombin time (PT) and platelet count (PLT) and blood rheology index, statistics of the 2 groups the incidence of bleeding complications. Results Deep venous thrombosis in the observation group was significantly lower than the control group (P<0.05); the 2 group after 5D-D and FIB and 12 h after operation were significantly decreased (P<0.05), and the observation group and the control group in the same period were significantly decreased (P<0.05); 2 groups were PT, APTT, PLT showed no significant difference compared with the preoperative, and the observation group and the control group in the same period. There was no statistically significant difference ; 2 group 7 d after operation and high blood viscosity, whole blood viscosity, whole blood low shear viscosity, plasma viscosity and postoperative 12 h compared were significantly decreased (P<0.05), and the observation group with the same period compared with the control group decreased significantly (P<0.05); postoperative 7 d erythrocyte deformation index and postoperative 12 h were significantly increased (P<0.05), and the observation group and the control group in the same period compared significantly increased (P<0.05); the incidence of bleeding complications was not statistically significant 2 after the operation of group. Conclusion Hypercoagulability of low-dose aspirin helps improve puerpera after cesarean section, reduce blood viscosity, reduce the incidence of venous thrombosis, does not increase the incidence of bleeding, clinical application of good safety, which is worthy of clinical application.

cesarean sectionlower extremity deep vein thrombosisaspirin

杨梅

展开 >

淳安县第一人民医院 妇产科,浙江 杭州 311700

剖宫产 下肢深静脉血栓形成 阿司匹林

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 7
  • 15